NICE CG178 Psychosis and Schizophrenia in Adults: Treatment and Management - an evidence-based guideline?
National Institute for Health and Care Excellence (NICE) clinical guideline (CG)178 was published in 2014. NICE guidelines occupy an important international position. We argue that CG178 overemphasises the use of cognitive-behavioural therapy for schizophrenia and those 'at risk' of psychosis, with recommendations that do not always reflect the evidence base. The CG178 recommendations on medications are limited.
Mark Taylor, MD, FRCPsych, FRANZCP, Royal Edinburgh Hospital, Edinburgh, UK, and University of Queensland, Brisbane, Australia; Udayanga Perera, MBBS, MD, District General Hospital, Monaragala, Sri Lanka.
Mark
M
Taylor
Mark Taylor, MD, FRCPsych, FRANZCP, Royal Edinburgh Hospital, Edinburgh, UK, and University of Queensland, Brisbane, Australia; Udayanga Perera, MBBS, MD, District General Hospital, Monaragala, Sri Lanka.
Udayanga
U
Perera
D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D015928:Cognitive Behavioral Therapy / Q000379:methods*; D019468:Disease Management; D019317:Evidence-Based Medicine; D006801:Humans; D017410:Practice Guidelines as Topic / Q000592:standards*; D011618:Psychotic Disorders / Q000628:therapy*; D012559:Schizophrenia / Q000628:therapy*
D014150:Antipsychotic Agents